Manufacturers Life Insurance Company, The Palatin Technologies Inc Transaction History

Manufacturers Life Insurance Company, The

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Aug 10, 2020	SELL	$0.41 - $0.73 $62,559 - $111,387	-152,585 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$0.36 - $0.79 $10,381 - $22,781	28,837 Added 23.3%	152,585 $65,000
Q4 2019 Feb 14, 2020	SELL	$0.75 - $0.89 $7,819 - $9,279	-10,426 Reduced 7.77%	123,748 $97,000
Q3 2019 Nov 12, 2019	SELL	$0.78 - $1.09 $8,179 - $11,429	-10,486 Reduced 7.25%	134,174 $119,000
Q2 2019 Aug 14, 2019	BUY	$0.98 - $1.64 $1,928 - $3,227	1,968 Added 1.38%	144,660 $168,000
Q1 2019 May 13, 2019	SELL	$0.67 - $1.01 $10,315 - $15,549	-15,396 Reduced 9.74%	142,692 $140,000
Q4 2018 Feb 14, 2019	BUY	$0.63 - $1.0 $6,294 - $9,991	9,991 Added 6.75%	158,088 $112,000
Q3 2018 Nov 14, 2018	SELL	$0.88 - $1.1 $12,125 - $15,156	-13,779 Reduced 8.51%	148,097 $148,000
Q2 2018 Aug 14, 2018	BUY	$0.91 - $1.45 $145,158 - $231,296	159,515 Added 6756.25%	161,876 $157,000
Q1 2018 May 15, 2018	BUY	$0.84 - $1.18 $951 - $1,336	1,133 Added 92.26%	2,361 $3,000
Q4 2017 Feb 08, 2018	BUY	$0.68 - $1.0 $835 - $1,228	1,228	1,228 $1,000

2.94K

Ticker PTN
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 9,290,480
Market Cap $7.15M
Description
Palatin Technologies, Inc., a biopharmaceutical company, develops targeted receptor-specific therapeutics for the treatment of various diseases in the United States. The company's lead product is Vyleesi, a melanocortin receptor (MCr) agonist for the treatment of premenopausal women with hypoactive sexual desire disorder. It is also developing o...

Get notified when there are updates to the investment portfolio of Manufacturers Life Insurance Company, The, based on Form 13F filings with the SEC.

Stay updated on Manufacturers Life Insurance Company, The with notifications on news.